Connection

Giuliano Rizzardini to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications Giuliano Rizzardini has written about Antibodies, Monoclonal.
Giuliano Rizzardini
Connection Strength
0.047
Antibodies, Monoclonal
  1. Efficacy of bezlotoxumab based on timing of administration relative to start of antibacterial therapy for Clostridium difficile infection. J Antimicrob Chemother. 2018 09 01; 73(9):2524-2528.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.